CC

Caxton Corporation Portfolio holdings

AUM $9.85M
This Quarter Return
+19.69%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$24.2M
AUM Growth
+$24.2M
Cap. Flow
+$744K
Cap. Flow %
3.08%
Top 10 Hldgs %
99.75%
Holding
13
New
1
Increased
3
Reduced
1
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
XERS icon
1
Xeris Biopharma Holdings
XERS
$1.26B
$14.6M 60.31%
5,113,348
RZLT icon
2
Rezolute
RZLT
$619M
$6.4M 26.47%
1,318,967
SPY icon
3
SPDR S&P 500 ETF Trust
SPY
$658B
$1.64M 6.81%
2,867
+998
+53% +$573K
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.09T
$530K 2.19%
1,151
+126
+12% +$58K
BCAX
5
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
$279K 1.15%
+10,941
New +$279K
MNMD icon
6
MindMed
MNMD
$676M
$194K 0.8%
34,073
+3,690
+12% +$21K
LXEO icon
7
Lexeo Therapeutics
LXEO
$259M
$161K 0.67%
17,851
ABVX
8
Abivax
ABVX
$6.12B
$131K 0.54%
11,365
-2,535
-18% -$29.2K
KYTX icon
9
Kyverna Therapeutics
KYTX
$160M
$112K 0.47%
22,981
CMPX icon
10
Compass Therapeutics
CMPX
$483M
$80K 0.33%
43,465
CNTX icon
11
Context Therapeutics
CNTX
$75.4M
$36.1K 0.15%
18,403
ACET icon
12
Adicet Bio
ACET
$59.9M
$25.2K 0.1%
17,488
MTEM
13
DELISTED
Molecular Templates, Inc.
MTEM
-136,866
Closed -$157K